REPORTS AND SPECIFICATIONS
Testing & COAs
Product records, original source files, and the scope of available documentation.
PRODUCT & DOCUMENT INDEX
FormulationComposition recordBatch reportsProfile
Composition ≠ batch analysisFull document index →
Historical internal QA documents
Original supplied PDFs are preserved. These summaries list input-based active values, raw-material HPLC entries, and named screening methods; underlying laboratory reports and independent verification were not supplied. They do not establish the current RUO specifications.
BPC-157 L1430Internal QA summary · Document available
- Scope
- Historical internal QA record, lot L1430. BPC-157 oral film: active content by input, raw-material purity by HPLC, heavy metals (USP 233), microbials (USP 2021/2022).
- Issuer
- Quality Assurance / VP of Quality sign-offs; legal issuer not identified.
- Laboratory
- Not identified in source; underlying analytical reports not supplied.
- Report date / identifier
- 2026-08-13 / ST00370
- Interpretation
- By-Input is not a finished-film content assay. Raw-material HPLC values are not finished-film purity. No issuer verification destination is supplied.
Semax / Selank L1431Internal QA summary · Document available
- Scope
- Historical internal QA record, lot L1431. Selank + Semax oral film: active content by input, raw-material purity by HPLC, heavy metals (USP 233), microbials (USP 2021/2022).
- Issuer
- Quality Assurance / VP of Quality sign-offs; legal issuer not identified.
- Laboratory
- Not identified in source; underlying analytical reports not supplied.
- Report date / identifier
- 2026-08-18 / ST00374
- Interpretation
- By-Input is not a finished-film content assay. Raw-material HPLC values are not finished-film purity. No issuer verification destination is supplied.
CJC-1295 + Ipamorelin L1432Internal QA summary · Document available
- Scope
- Historical internal QA record, lot L1432. CJC-1295 + Ipamorelin oral film: active content by input, raw-material purity by HPLC, heavy metals (USP 233), microbials (USP 2021/2022).
- Issuer
- Quality Assurance / VP of Quality sign-offs; legal issuer not identified.
- Laboratory
- Not identified in source; underlying analytical reports not supplied.
- Report date / identifier
- 2026-08-17 / ST00371
- Interpretation
- By-Input is not a finished-film content assay. Raw-material HPLC values are not finished-film purity. No issuer verification destination is supplied.
DSIP L1433Internal QA summary · Document available
- Scope
- Historical internal QA record, lot L1433. DSIP oral film: active content by input, raw-material purity by HPLC, heavy metals (USP 233), microbials (USP 2021/2022).
- Issuer
- Quality Assurance / VP of Quality sign-offs; legal issuer not identified.
- Laboratory
- Not identified in source; underlying analytical reports not supplied.
- Report date / identifier
- 2026-08-17 / ST00372
- Interpretation
- By-Input is not a finished-film content assay. Raw-material HPLC values are not finished-film purity. No issuer verification destination is supplied.
MOTS-c + NAD+ L1434Internal QA summary · Document available
- Scope
- Historical internal QA record, lot L1434. MOTS-c + NAD+ oral film: active content by input, raw-material purity by HPLC, heavy metals (USP 233), microbials (USP 2021/2022).
- Issuer
- Quality Assurance / VP of Quality sign-offs; legal issuer not identified.
- Laboratory
- Not identified in source; underlying analytical reports not supplied.
- Report date / identifier
- 2026-08-17 / ST00373
- Interpretation
- By-Input is not a finished-film content assay. Raw-material HPLC values are not finished-film purity. No issuer verification destination is supplied.
